| |
| |
|
| Insider
Information: |
Ho Carole |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
143,605 |
|
|
Indirect Shares
|
208,219 |
|
|
| Direct
Value |
$2,880,716 |
|
|
|
Indirect Value
|
$4,176,873 |
|
|
| Total
Shares |
351,824 |
|
|
| Total
Value |
$7,057,589 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 21.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-01 |
4 |
AS |
$18.64 |
$107,646 |
D/D |
(5,775) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-04 |
4 |
AS |
$18.49 |
$72,015 |
D/D |
(3,869) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-05 |
4 |
AS |
$18.83 |
$147,928 |
D/D |
(7,856) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-01 |
4 |
AS |
$22.17 |
$129,495 |
D/D |
(5,775) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-04 |
4 |
AS |
$21.87 |
$129,776 |
D/D |
(5,863) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-05 |
4 |
AS |
$21.96 |
$128,730 |
D/D |
(5,862) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-14 |
4 |
AS |
$25.01 |
$12,505 |
D/D |
(500) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-01 |
4 |
AS |
$23.91 |
$138,080 |
D/D |
(5,775) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-02 |
4 |
AS |
$24.51 |
$152,503 |
D/D |
(6,135) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-02 |
4/A |
AS |
$24.51 |
$155,194 |
D/D |
(6,242) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-03 |
4 |
AS |
$26.27 |
$154,319 |
D/D |
(5,862) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
AS |
$23.50 |
$61,406 |
D/D |
(2,613) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
AS |
$22.86 |
$60,792 |
D/D |
(2,653) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
AS |
$22.17 |
$56,445 |
D/D |
(2,546) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-06-10 |
4 |
AS |
$18.62 |
$86,711 |
D/D |
(4,617) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-12-23 |
4 |
AS |
$20.01 |
$69,315 |
D/D |
(3,464) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-14 |
4 |
OE |
$5.28 |
$2,640 |
D/D |
500 |
500 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
OE |
$5.28 |
$13,443 |
D/D |
2,546 |
2,546 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
OE |
$5.28 |
$13,797 |
D/D |
2,613 |
2,613 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
OE |
$5.28 |
$14,008 |
D/D |
2,653 |
2,653 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-03 |
4 |
AS |
$18.90 |
$52,485 |
D/D |
(2,777) |
2,777 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4 |
AS |
$19.30 |
$118,084 |
D/D |
(5,950) |
2,777 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-03-30 |
4 |
S |
$19.48 |
$27,817 |
D/D |
(1,428) |
2,822 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-12-20 |
4 |
AS |
$20.00 |
$17,200 |
D/D |
(860) |
3,464 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-04 |
4 |
OE |
$5.28 |
$20,428 |
D/D |
3,869 |
3,869 |
0 |
- |
|
108 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
